Sarepta Therapeutics Inc (BSP:S1RP34)
R$ 37.72 -0.52 (-1.36%) Market Cap: 72.06 Bil Enterprise Value: 73.29 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 79/100

Q3 2024 Sarepta Therapeutics Inc Earnings Call Transcript

Nov 06, 2024 / 09:30PM GMT
Release Date Price: R$35.68 (-0.22%)
Operator

Good day and welcome to the Sarepta Therapeutics third-quarter 2024 financial results conference call. (Operator Instructions)

Mary;Jane Elliott
Sarepta Therapeutics Inc - Associate Director, Investor Relations and Corporate Communications

As a reminder, today's conference is being recorded. I'd like to turn the call over to Mary Jane can associate director, investor relations and corporate communications locations. Please go ahead. Doesn't sound like you all for joining today's call. Earlier this afternoon, we released our financial results for the third quarter 2020 for the press release is available on our website at synaptics.com, and our 10 K was filed with the Securities Exchange Act May 20th. On the call today are Doug Ingram in Appleton down Marie and Dr. Louise Rodino-Klapac, Quebec. After our formal remarks, we'll open the call for Q&A. I'd like to note that during this call, we will make will be making a number of forward-looking statements for a moment to review our slide on the webcast, which contains our forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot